This study of initially remitted patients (at 1 year after index treatment entry) found that predictors of relapse were not moderated by non-problem versus abstinence at 1 year after intake. Thus in this treatment sample we did not find evidence that predictors of relapse were unique for non-problem users versus abstainers.